CERTIFIED MEDICATION ASSISTED TREATMENT (MAT) ADVOCATE (CMA)-1

The Basic Advocacy Training Session

The training for certification includes a variety of topics to give advocates a well-grounded understanding of MAT, research, regulations and laws that protect MAT patients and programs.

  1. Medication Assisted Treatment  Basic clinical information about methadone and buprenorphine treatment.

  2. Regulations and Accreditation The federal regulations will be explained:  What they are and how they relate to the state regulations? Accreditation and what an accreditation survey is, how it is done, and how advocates can be involved.

  3. The Basics of Advocacy The different kinds of advocacy from “Hands On” Individual Advocacy (handling a grievavce), Networking, Systems Advocacy, Working with Policy Makers and Politicians.

  4. Stigma and Prejudice Patients themselves are often the greatest spreaders of stigma through ignorance and myths. Stigma will only end when society is educated about the effectiveness and benefits of MAT from the bottom up. We need to start with patients who can become ambassadors for MAT but this will be most effective with the support of policy makers and regulating agencies. The Media also spreads misinformation and stigma about MAT. Advocates need to have basic skills to work with the Media and write an Editorial, Letter to the Editor LTE and a Press Release.

  5. Advocate Certification What is certification and how it will professionalize those committed to MAT advocacy.  The Advocates Code of Ethics, the Goals of MAT Advocacy, and Advocate Certification.

Similar Posts

  • AMTA’S Five-Year Plan for Methadone Treatment In the United States

    Admin 05/30/2023

    AMTA’S Five-Year Plan for Methadone Treatment In the United States Presented at the Policy Makers Luncheon National Methadone Conference St. Louis, October 7-10, 2001 Accreditation (2001-2005) CSAT implemented new federal standards for accrediting methadone treatment programs on May 18, 2001. I submitted AMTA’s testimony in support of accreditation during my presentation to the Federal Interagency…

  • National Alliance of Methadone Advocates Inc 435 Second Avenue New York, NY 10010      

    Admin 09/21/2021

    Membership Application Name:   _______________________________________________________   Mr. ___  Ms. ___  Dr. ___ Organization:  __________________________________________________________________________ Title:  _____________________________________________  Degree(s):  ________________________ Address:  _____________________________________________________________________________ Address:  _____________________________________________________________________________ City:   __________________________________   State:   ____________   Postal Code:   _____________ Email:  ______________________________________  Country:   ________________________________ Home Phone: (____)___________________________   Work Phone:  (____)_______________________ Alternate Phone:  (____)________________________   Fax:  (____)______________________________ If you have email may we send you bulletin alerts electronically. (This will get bulletin alerts to you quicker than usual mail)   Yes  _____   No _____ Types of Membership $_______ Individual Membership   Dues: $25 a…

  • The National Methadone Conference-3

    Admin 05/13/2023

    American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Session: Organizational Meeting April 15, 2003 Picture Essay of NAMA’s Organizational Meeting Starting the Meeting Joyce calls the meeting to order. Top (l-r) Robert Sanders (NYC NAMA), Becki Ballard (OK NAMA), Gary Nessenbaum (WAMM), Jennifer Nelson Connelly (PA NAMA), Joycelyn Woods,…

  • Grievance Report

    Admin 04/02/2022

    Is Your Program Punitive? Fill Out a Grievance Report — It’s Time To Educate Them! Does Your Program Treat Patients With Dignity? Fill Out a Compliment Report — Let Them Know They are Appreciated! The Grievance Report Project is an ongoing project used to educate the Medication Assisted Treatment (MAT) community about quality treatment. Programs…

  • Oral Swabs

    Admin 08/23/2022

    Policy Statement Number 13 July 2003 The development of Oral Swabs for toxicology testing shows potential in providing an alternative means to test for drug use and to assess if a patient is taking their medication as prescribed. Such advances in technology should improve the quality of treatment that programs can provide to patients. However…